| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 08/09/2006 | CN1813958A Respiratory medicine for treating cancer, production method there for and specific application tool |
| 08/09/2006 | CN1813901A Use offructus schisandrae sphenantherae and its extract for multidrug resistance for treating tumour |
| 08/09/2006 | CN1813899A Anti cancer Chinese medicine for mulation and its preparing method |
| 08/09/2006 | CN1813884A Use of delphinium glabra plant for preparing drug for stopping pain, hemostasis and anticancer |
| 08/09/2006 | CN1813870A Medicinal composition for antitumor and regulating body immunological competence and its preparing method |
| 08/09/2006 | CN1813869A Medicine for antitumor and regulating body immunological competence and its preparing method |
| 08/09/2006 | CN1813831A Glabrous sarcandra herb lyophilized powder for injection, its high-dose injection and preparing method |
| 08/09/2006 | CN1813828A Oil seed bruceae lyophilized powder for injection and its preparing method |
| 08/09/2006 | CN1813819A Hedgehog hydnum fruiting body or hyphostroma and culture extract and formulation and preparing method |
| 08/09/2006 | CN1813804A External-use ointment and its preparing method |
| 08/09/2006 | CN1813802A Bufonid skin extract production process |
| 08/09/2006 | CN1813778A Method for preparing baicalin injection |
| 08/09/2006 | CN1813748A Novel medicinal composition and its formulation |
| 08/09/2006 | CN1813736A Tetrandrine emulsion for injection and its preparing method |
| 08/09/2006 | CN1813723A Application of gaba-receptor modulators for the preventing/or treatment of neurodegenerative diseases of the eye |
| 08/09/2006 | CN1813721A Epothilone B liposome formulation and use |
| 08/09/2006 | CN1813720A Epothilone slow-release implanting composition and use |
| 08/09/2006 | CN1813715A Ginkgolide B dropping pill and its preparing method |
| 08/09/2006 | CN1813714A Ginkgolide B soft capsule and its preparing method |
| 08/09/2006 | CN1813692A Irisquinonum injection emulsion and its preparing method |
| 08/09/2006 | CN1813685A Couted particle for reinforcing pidotimod acid-base stability, and its production method and use |
| 08/09/2006 | CN1813684A Method for preparing 5-fluorouracil/chitosan nano drug-carrying microsphere |
| 08/09/2006 | CN1813679A Taxane liposome lyophilized composition and its preparing method |
| 08/09/2006 | CN1813677A Quercetin long-acting liposome powder for injection and its preparing method |
| 08/09/2006 | CN1813676A Anthracene ring antitumor medicinal liposome and its production process |
| 08/09/2006 | CN1268753C Method for transfer of molecular substances with prokaryontic nucleic acid-binding proteins |
| 08/09/2006 | CN1268743C genetic construct for coding cell targeting part and heterologous precursor activating enzyme, and its application |
| 08/09/2006 | CN1268741C Therapy for 'alpha'-galactosidase deficiency |
| 08/09/2006 | CN1268645C Therapeutic compounds comprised of anti-FC receptor binding agents |
| 08/09/2006 | CN1268636C Dolastatin 15 derivatives |
| 08/09/2006 | CN1268630C Synthesis for compound of diamine bridge linking ortho phenanthroline hydrous lanthanum (III) and anti-cancer activity thereof |
| 08/09/2006 | CN1268625C Cyclic amp-specific phosphodiesterase inhibitors |
| 08/09/2006 | CN1268624C A novel crystalline form of 6-hydroxy-3-(4-[2-(piperidine-1-yl)ethoxy] phenoxy)-2-(4-methoxyphenyl) benzo[b] thiophene hydrochloride |
| 08/09/2006 | CN1268619C Preparing of polyene taxol trihydrate |
| 08/09/2006 | CN1268394C Binding domain-immunoglobulin fusion proteins |
| 08/09/2006 | CN1268381C Leukopenia treating Chinese traditional medicine |
| 08/09/2006 | CN1268348C Antineoplastic combination of medication |
| 08/09/2006 | CN1268336C Pharmaceutical composition, dosage form, and method of epothilones for oral administration |
| 08/09/2006 | CN1268335C Nucleoside analogs with carboxamidine wodified monocyclic base |
| 08/09/2006 | CN1268333C Indolinone compounds for the treatment of disease |
| 08/09/2006 | CN1268328C Coenzyme q and eicosapentaenoic acid (EPA) |
| 08/09/2006 | CN1268324C Chinese medicinal soft capsule and preparing process thereof |
| 08/09/2006 | CN1268323C Rhodiola sacra soft capsule and its preparation |
| 08/09/2006 | CN1268319C Rhodiola sacra injection and its preparation |
| 08/09/2006 | CA2602083A1 Oxime and hydroxylamine substituted thiazolo(4,5-c) ring compounds and methods |
| 08/08/2006 | USRE39229 libraries of DNA sequences encoding zinc finger binding motifs for display on a particle; designing zinc finger binding polypeptides for binding to a target sequence |
| 08/08/2006 | US7087759 for controlling weight; pyrrolidine or piperidine compounds |
| 08/08/2006 | US7087758 Quinoline inhibitors of hyaki and hyak3 kinases |
| 08/08/2006 | US7087755 2-substituted pyridine-4-boronic acids created by reacting a metallated pyridine with an electrophile; useful in combinatorial approaches by virtue of their boronic moiety and at least one additional functional group |
| 08/08/2006 | US7087751 Diazotizing 5-amino-1H-imidazole-4-carboxamide derivative having divalent protecting group on amide that is readily removable by hydrolysis or hydrogenolysis |
| 08/08/2006 | US7087724 Carrier molecules |
| 08/08/2006 | US7087718 C-type lectin transmembrane antigen expressed in human prostate cancer and uses thereof |
| 08/08/2006 | US7087715 Human paris-1 antigen and nucleic acids: diagnostic and therapeutic uses |
| 08/08/2006 | US7087712 Peptide for triggering an immune reaction against tumor cells |
| 08/08/2006 | US7087642 Inhibitors of IMPDH enzyme |
| 08/08/2006 | US7087641 4β-1″-[(2″-substituted benzoyl) anilino]podophyllotoxin analogues useful as anticancer agents |
| 08/08/2006 | US7087637 Substituted indoles which are PARP inhibitors |
| 08/08/2006 | US7087636 A 4,7-methano-1,2-benzisothiazol-3-one-1,1-dioxide derivatives, for treating cancer, immune modulation |
| 08/08/2006 | US7087634 Cyclic AMP-specific phosphodiesterase inhibitors |
| 08/08/2006 | US7087632 Inhibition of the interaction of RAGE with its ligands; treatment acute and chronic inflammation, the development of diabetic late complications, Alzheimer's disease, erectile dysfunction, and tumor invasion and metastasis. |
| 08/08/2006 | US7087627 Synergistic mixture of vasculation damaging agent such as tubulin binding agent and inhibitor of forming of nitric oxide; antitumor agents; anticancer agents |
| 08/08/2006 | US7087626 TGF-beta signal transduction inhibitors |
| 08/08/2006 | US7087614 Pyrimidine inhibitors of phosphodiesterase (PDE) 7 |
| 08/08/2006 | US7087613 Treating abnormal cell growth with a stable polymorph of N-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)-4-quinazolinamine hydrochloride |
| 08/08/2006 | US7087603 Pyrazole compounds useful as protein kinase inhibitors |
| 08/08/2006 | US7087600 Anticancer agents; side effect reduction |
| 08/08/2006 | US7087599 Estrogen receptor modulators |
| 08/08/2006 | US7087590 19-norbufalin derivatives, their preparation and pharmaceutical compositions containing them |
| 08/08/2006 | US7087586 Oligonucleotide compositions and their use to induce differentiation of cells |
| 08/08/2006 | US7087584 Detection and modulation of IAPs and NAIP for the diagnosis and treatment of proliferative disease |
| 08/08/2006 | US7087432 Fad4, Fad5, Fad5-2 and Fad6, novel fatty acid desaturase family members and uses thereof |
| 08/08/2006 | US7087405 Anticancer agents; rheumatic diseases; genetic engineered plasmid |
| 08/08/2006 | US7087249 Nanocrystalline antimicrobial metals (noble metals)formed with atomic disorder are capable of releasing highly active clusters of the antimicrobial metal sufficient to cause microbiocidal effect; anti-inflammatory activity |
| 08/08/2006 | US7087244 Thermogelling oligopeptide polymers |
| 08/08/2006 | US7087233 Preventing fetal damage by administering germination activated Ganoderma lucidum spore powder to a pregnant mammal |
| 08/08/2006 | US7087214 Water-soluble porphyrin platinum compounds of the tetraarylporphyrin platinum derivatives type or of the hematoporphyrin platinum derivatives type with high tumor selectivity and their use for the treatment of benign and |
| 08/08/2006 | US7087212 Multilayer binding; lamellar surface structure |
| 08/08/2006 | CA2356985C 5ht1 antagonists for antidepressant therapy |
| 08/06/2006 | WO2006058869A2 Substituted pteridines for treating inflammatory diseases |
| 08/06/2006 | CA2587269A1 Substituted pteridines for treating inflammatory diseases |
| 08/03/2006 | WO2006081337A2 Erastin analogues and their uses for killing cancer cells |
| 08/03/2006 | WO2006081251A2 Methods and compositions using 4-amino-2-(3-methyl-2,6-dioxopiperidin-3-yl)-isoindole-1-3-dione |
| 08/03/2006 | WO2006081230A2 3-(indazol-5-yl)-(1,2, 4) triazine derivatives and related compounds as protein kinase inhibitors for the treatment of cancer |
| 08/03/2006 | WO2006080564A1 RNAi THERAPEUTIC AGENT HAVING NO ADVERSE SIDE EFFECT |
| 08/03/2006 | WO2006080509A1 Novel pyrimidine nucleoside compound or its salt |
| 08/03/2006 | WO2006080463A1 Therapeutic agent for cancer and recurrence preventive each containing vitamin k hydroquinone derivative |
| 08/03/2006 | WO2006080450A1 Igf-1r inhibitor |
| 08/03/2006 | WO2006080420A1 Antigen-specific t cell inducer, antibody production inducer, immune enhancer and vaccine |
| 08/03/2006 | WO2006080327A1 ANTICANCER DRUG CONTAINING α,α,α-TRIFLUOROTHYMIDINE AND THYMIDINE PHOSPHORYLASE INHIBITOR |
| 08/03/2006 | WO2006080243A1 Coated magnetic particle containing preparation, process for producing the same and diagnostic therapeutic system |
| 08/03/2006 | WO2006080171A1 Immunopotentiating agent |
| 08/03/2006 | WO2006080118A1 Composition for inhibiting expression of target gene |
| 08/03/2006 | WO2006079791A1 Chemical compounds |
| 08/03/2006 | WO2006079789A1 Pyrimidothiophene compounds having hsp90 inhibitory activity |
| 08/03/2006 | WO2006079731A2 Use of cacao polyphenols for treating a prostate hyperplasia, a specific cacao extract and applications |
| 08/03/2006 | WO2006079645A1 Novel indolopyridines , benzofuranopyridines and benzothienopyridines |
| 08/03/2006 | WO2006079644A1 Indolopyridines, benzofuranopyridines and benzothienopyridines |
| 08/03/2006 | WO2006079539A2 Use of pyrimidylaminobenzamides for the treatment of diseases that respond to modulation of tie-2 kinase activity |
| 08/03/2006 | WO2006079478A1 2-phenylquinoxalines as inhibitors for mpp1 |
| 08/03/2006 | WO2006079291A1 Artificial synthetic single strand deoxynucleotide and vaccine composition thereof and the use |